KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $90.0 million.

  • Gilead Sciences' Depreciation & Amortization (CF) fell 425.53% to $90.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $375.0 million, marking a year-over-year decrease of 53.05%. This contributed to the annual value of $381.0 million for FY2024, which is 762.71% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Depreciation & Amortization (CF) is $90.0 million, which was down 425.53% from $93.0 million recorded in Q2 2025.
  • Gilead Sciences' 5-year Depreciation & Amortization (CF) high stood at $98.0 million for Q2 2024, and its period low was $78.0 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $90.0 million (2021), whereas its average is $87.7 million.
  • As far as peak fluctuations go, Gilead Sciences' Depreciation & Amortization (CF) plummeted by 777.78% in 2022, and later skyrocketed by 1807.23% in 2024.
  • Over the past 5 years, Gilead Sciences' Depreciation & Amortization (CF) (Quarter) stood at $90.0 million in 2021, then decreased by 7.78% to $83.0 million in 2022, then grew by 9.64% to $91.0 million in 2023, then rose by 4.4% to $95.0 million in 2024, then dropped by 5.26% to $90.0 million in 2025.
  • Its last three reported values are $90.0 million in Q3 2025, $93.0 million for Q2 2025, and $97.0 million during Q1 2025.